American Conference Institute (ACI) will be presenting a National Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities and Gene Therapies from March 21-22, 2023, in Boston, MA. The Forum will highlight leveraging technology, safeguarding IP, and securing funding to accelerate development in mRNA, CRISPR, and CAR-T.
The Forum promises to be a holistic, end-to-end summit for therapeutic pioneers, innovators, investors, executives and their counsel to meet, assess, and shape the future development and commercialization of these novel modalities and therapies. Confirmed speakers include Julia Tierney (Chief of Staff, Food and Drug Administration), Anne Gussow (Supervisory Patent Examiner, Quality Assurance Specialist, USPTO), Karlheinz Skowronek (Supervisory Patent Examiner, Bioinformatics, USPTO), and Julie Wu (Supervisory Patent Examiner, Immunotherapy and Recombinant Antibodies, USPTO).
A brochure, agenda, and registration information including lodgings can be found here. ACI can be contacted by e-mail at [email protected] and by telephone at 1-888-224-2480.
Patent Docs readers can save 10% by using promo code: D10-999-PATENTDOCS.
Comments